Follow the Money Part 2: Point-of-Sale Rebates


This video is the second in a series on following the flow of rebate dollars. See Part 1 here.

Recently, because of the increased use of high deductible health plans and high-cost specialty drugs, there is growing momentum to disperse rebate dollars directly to members as a point-of-sale rebate to help the individual patient lower the cost of an individual prescription drug. The concept of point-of-sale rebates has been around for quite some time. Some programs that allow the patient to receive the point-of-sale rebate don’t always get the same cost offset.

Now, what about point-of-sale rebates? How about we put the rebate into the price of the prescription? If it’s a $1,000 prescription and it has a $100 rebate, why not make the prescription $900. You can do that, but the problem is that the pharmacy benefit management company (PBM) hasn’t earned the rebate money yet. They still have to pay the drug store $1,000. So if the PBM is going to collect only $900 from either the patient in the form of a copayment or coinsurance, or from the plan sponsor, or a combination of both, the PBM doesn’t have the rebate money in their hand – yet they’ve applied it and lowered the price of that prescription.

Essentially the PBM has become a bank because they have to fund the $100 rebate before they’ve actually collected it from the pharma company. Because this is done in real-time, the PBM assumes risk. To assume that risk, the PBM only funds the point-of-sale rebate at a factor. For every $100 of rebate that is potentially earned, they may only use 80% in the point-of-sale rebate because they haven’t collected the money yet – and they are not a bank. Once they do collect the rebate money, there is some backend reconciliation. Unfortunately, that reconciliation is at the plan sponsor level, not at the patient level.

Point-of-sales rebates are not a dollar-for-dollar equivalent, but it is a way to get money to the patients who perhaps can afford the drugs the least. Employers have decisions to make – should I take the traditional rebate in arrears at 100% value, or should I take a discounted value upfront to lower the cost for my members, and then have some mechanism for true-up on the backend.

Get Our Newsletter

Stay informed with expert advice and actionable insights to optimize pharmacy benefits, reduce costs and enhance member care.

This field is for validation purposes and should be left unchanged.

recaptcha logo This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.